Loading
Latest filing published 23 Apr 2025 for Enfusion, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Roy Luo, listed as senior executive, appears in our data through filings on Enfusion, Inc. shares, published by SEC (Form 4). Between 25 October 2021 and 21 April 2025, the trades on record add up to 5 filings.
Purchases make up the whole of the open-market record (2 purchases, €18.5M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 23 April 2025 with a transaction in Enfusion, Inc. The latest purchase dates back some time: it was published 1,822 days ago, on 27 October 2021. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.